In today’s recent session, 0.5 million shares of the Mind Medicine Inc (NASDAQ:MNMD) have been traded, and its beta is 1.75. Most recently the company’s share price was $8.27, and it changed around $0.01 or 0.12% from the last close, which brings the market valuation of the company to $606.45M. MNMD at last check was trading at a discount to its 52-week high of $12.22, offering almost -47.76% off that amount. The share price’s 52-week low was $4.18, which indicates that the recent value has risen by an impressive 49.46% since then. We note from Mind Medicine Inc’s average daily trading volume that its 10-day average is 2.9 million shares, with the 3-month average coming to 1.74 million.
Mind Medicine Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.10. If we narrow it down even further, the data shows that 0 out of 11 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 0 recommended MNMD as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Mind Medicine Inc is expected to report earnings per share of -0.28 for the current quarter.
Mind Medicine Inc (NASDAQ:MNMD) trade information
Instantly MNMD has been showing a green trend so far today with a performance of 0.12% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 10.20 on recent trading dayincreased the stock’s daily price by 18.92%. The company’s shares are currently up 18.82% year-to-date, but still up 12.21% over the last five days. On the other hand, Mind Medicine Inc (NASDAQ:MNMD) is 16.97% up in the 30-day period. We can see from the shorts that 10.43 million shares have been sold at a short interest cover period of 7.73 day(s).
The consensus price target as assigned by Wall Street analysts is $14, which translates to bulls needing to increase their stock price by 40.93% from its current value. Analyst projections state that MNMD is forecast to be at a low of $14 and a high of $14.
Mind Medicine Inc (MNMD) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 2.29%. Mind Medicine Inc earnings are expected to increase by 41.32% in 2025, but the outlook is positive 14.93% per year for the next five years.
Mind Medicine Inc (NASDAQ:MNMD)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.72% of Mind Medicine Inc shares, and 68.86% of them are in the hands of institutional investors. The stock currently has a share float of 69.36%.
iShares Russell 2000 ETF and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Nov 30, 2024. The former held 2.03 shares worth $16.85 million, making up 2.77% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 1.05 shares worth around $8.72 million, which represents about 1.43% of the total shares outstanding.
